Maintenance treatment of preterm labor with the oxytocin antagonist atosiban
- 30 May 2000
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 182 (5), 1184-1190
- https://doi.org/10.1067/mob.2000.105816
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescueAmerican Journal of Obstetrics and Gynecology, 2000
- Double‐blind evaluation of ritodrine sustained release for oral maintenance of tocolysis after active preterm labourBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- The effect of the oxytocin antagonist atosiban on preterm uterine activity in the humanAmerican Journal of Obstetrics and Gynecology, 1994
- Uterine oxytocin gene expression: a novel framework for oxytocin actionRegulatory Peptides, 1993
- Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safetyAmerican Journal of Obstetrics and Gynecology, 1993
- Treatment of Preterm Labor with the Beta-Adrenergic Agonist RitodrineNew England Journal of Medicine, 1992
- Follow-up of Prematurely Born InfantsClinical Obstetrics and Gynecology, 1988
- Beta‐mimetics in preterm labour: an overview of the randomized controlled trialsBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Oxytocin receptors in the human uterus during pregnancy and parturitionAmerican Journal of Obstetrics and Gynecology, 1984
- Oral ritodrine maintenance in the treatment of preterm laborAmerican Journal of Obstetrics and Gynecology, 1980